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I N T RODUC T I ON
Since the early days of investigation of ion channel 
function to the present day in which functional studies 
of ion channels are also guided by structural informa-
tion, molecules that inhibit ion channels continue to be 
essential tools for probing state-dependent conforma-
tional changes in binding-site accessibility. For potas-
sium channels (K+ channels), some of the earliest work 
with channel blockers insightfully established that state-
dependent conformational changes on the cytosolic 
side of voltage-dependent K+ channels are required to 
allow charged quaternary blockers to reach their block-
ing position within the pore (Armstrong, 1969; Armstrong 
and Hille, 1972; Choi et al., 1991). Furthermore, for 
many Kv channels, channel closure can only occur after 
exit of the blocker from its blocking position (Armstrong 
and Hille, 1972; Choi et al., 1993). This idea that there 
is gated access to the permeation pathway from the cy-
tosolic side of K+ channels was subsequently born out in 
structures of K+ channels (Doyle et al., 1998; Long et al., 
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Abbreviations used in this paper: bbTBA, N-(4-[benzoyl]benzyl)-N,N,N-
tributylammonium; BK, large conductance Ca2+- and voltage-activated K+; 
ChTX, charybdotoxin; C-O, closed–open; MTSEA, 2-aminoethyl MTS; 
MTSES, sodium (2-sulfanoethyl) MTS; MTSET, [2-(trimethylammonium)
ethyl] MTS bromide; NPo, open probability times the number of chan-
nels; Pc, closed probability; Po, open probability.
2005; Uysal et al., 2009). First, in closed K+ channels, 
the so-called crossing of the S6 helices provides a physi-
cal barrier to access of small molecules to an inner aque-
ous cavity preceding the selectivity filter. Second, in open 
K+ channels, separation of the S6 helices creates an 
aperture (Perozo et al., 1999) that allows access not 
only of permeant ions but also of quaternary blockers 
(Lenaeus et al., 2005) and peptides (Zhou et al., 2001) 
to positions within the inner cavity. Together, these 
types of functional and structural tests have provided a 
compelling picture of a category of channel inhibition 
that exclusively involves open-channel block; that is, 
binding sites for particular blockers only become avail-
able when the channel is open. However, ion channel 
inhibition can also occur by a variety of other mecha-
nisms, which can also be informative about channel 
function and its structural components. One particularly 
rich source of interesting channel blockers are naturally 
occurring toxins.
Evolutionary pressures for species to optimize their 
survival have resulted in a vast, useful, and only partially 
exploited array of naturally occurring compounds that 
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Paxilline, a tremorogenic fungal alkaloid, potently inhibits large conductance Ca2+- and voltage-activated K+ (BK)-
type channels, but little is known about the mechanism underlying this inhibition. Here we show that inhibition is 
inversely dependent on BK channel open probability (Po), and is fully relieved by conditions that increase Po, even 
in the constant presence of paxilline. Manipulations that shift BK gating to more negative potentials reduce inhibi-
tion by paxilline in accordance with the increase in channel Po. Measurements of Po times the number of channels 
at negative potentials support the idea that paxilline increases occupancy of closed states, effectively reducing the 
closed–open equilibrium constant, L(0). Gating current measurements exclude an effect of paxilline on voltage 
sensors. Steady-state inhibition by multiple paxilline concentrations was determined for four distinct equilibration 
conditions, each with a distinct Po. The IC50 for paxilline shifted from around 10 nM when channels were largely 
closed to near 10 µM as maximal Po was approached. Model-dependent analysis suggests a mechanism of inhibi-
tion in which binding of a single paxilline molecule allosterically alters the intrinsic L(0) favoring occupancy of 
closed states, with affinity for the closed conformation being >500-fold greater than affinity for the open conforma-
tion. The rate of inhibition of closed channels was linear up through 2 µM paxilline, with a slope of 2 × 106 M1s1. 
Paxilline inhibition was hindered by either the bulky cytosolic blocker, bbTBA, or by concentrations of cytosolic 
sucrose that hinder ion permeation. However, paxilline does not hinder MTSET modification of the inner cavity 
residue, A313C. We conclude that paxilline binds more tightly to the closed conformation, favoring occupancy of 
closed-channel conformations, and propose that it binds to a superficial position near the entrance to the central 
cavity, but does not hinder access of smaller molecules to this cavity.
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2009) that are potent nonpeptidergic blockers of BK 
channels, generally acting at low nanomolar concentra-
tions (Knaus et al., 1994; Imlach et al., 2009). Because 
some BK channels containing particular auxiliary  sub-
units exhibit resistance to block by the BK-blocking 
scorpion toxins, iberiotoxin and ChTX (Xia et al., 1999; 
Meera et al., 2000; Xia et al., 2000), paxilline, as a more 
general BK inhibitor, is often used in tests of physiologi-
cal roles of BK channels (Shao et al., 1999; Raffaelli 
et al., 2004; Tammaro et al., 2004; Essin et al., 2009). 
Although inhibition by paxilline has been termed allo-
steric and shows relief by elevations of Ca2+ (Sanchez 
and McManus, 1996), the mechanism and site of action 
of the lipophilic paxilline are unknown. Recently, we 
observed that mutation of the so-called hinge glycine 
position (G311) in the S6 helix thought to line the BK 
channel inner cavity totally abolishes paxilline inhibi-
tion (Zhou et al., 2010). This suggests that paxilline 
block is associated in some way with the BK pore-gate 
domain, perhaps dependent in some way on the confor-
mational status of the inner pore. Here, we establish 
that paxilline inhibition can best be viewed as an alloste-
ric effect on the BK channel closed–open (C-O) equi-
librium, stabilizing channels in closed conformations, 
while having no discernible direct blocking effect on 
open BK channels and no effect on voltage sensors. Oc-
cupancy of the paxilline-binding site does not directly 
occlude ion permeation, but binding shifts the channel 
C-O equilibrium, resulting in stabilization of channels 
in closed states.
MAT E R I A L S  AND  M E THOD S
General methods
Oocyte preparation, handling of RNA, and electrophysiological 
methods used here were identical to those described in other re-
cent papers from this laboratory (Tang et al., 2009; Zhou et al., 
2010). All experiments used excised inside-out patches in which 
solution exchange at the pipette tip was accomplished with a fast 
perfusion stepper system (SF-77B; Warner Instruments). Pipettes 
were typically 1–2 MΩ, except for patches used for open probabil-
ity (Po) times the number of channels (NPo) or gating current 
measurements, and were coated with Sylgard (Sylgard 184; Corn-
ing) before heat polishing. Gigaohm seals were formed while the 
oocytes were bathed in frog Ringer’s solution (mM: 115 NaCl, 2.5 
KCl, 1.8 CaCl2, and 10 HEPES, pH 7.4). After patch excision, the 
pipette tip was moved into flowing test solutions. The pipette solu-
tion (bathing the extracellular membrane face) contained (mM): 
140 K-methanesulfonate, 20 KOH, 10 HEPES, and 2 MgCl2, 
pH 7.0. The composition of the solution used to bathe the cyto-
plasmic face of patch membranes was (mM): 140 K-methanesulfo-
nate, 20 KOH, and 10 HEPES, with pH adjusted to 7.0. For 0 Ca2+, 
the solution also contained 5 mM EGTA; for 10 µM Ca2+, it con-
tained 5 mM HEDTA; and for 100 or 300 µM Ca2+, no Ca2+ buffer 
was included. For 10 µM Ca2+, the solution was titrated with a Ca2+-
methanesulfonate solution to obtain the desired Ca2+ concentra-
tion (Zhang et al., 2001), as defined with a Ca2+-sensitive electrode 
calibrated with commercial Ca2+ solutions (WPI). Measurements 
and fitting of current recordings were accomplished either with 
Clampfit (Molecular Devices) or with programs written in this 
may kill or incapacitate prey or limit predation (Bush 
et al., 1997; Han et al., 2008; Liang, 2008). Such com-
pounds often target ion channels, and the high selectiv-
ity and strong affinity for particular ion channels have 
proven of enormous value for the identification of par-
ticular subtypes of ion channels and their physiological 
roles. Many such toxins are thought to act simply by 
binding to the extracellular face of an ion channel, per-
haps in a largely state-independent fashion, thereby 
occluding ion permeation or preventing channel open-
ings. This would include toxins such as tetrodotoxin 
acting on Na+ channels (Narahashi et al., 1964, 1967), 
charybdotoxin (ChTX) acting on large conductance 
Ca2+- and voltage-activated K+ (BK)-type K+ channels 
(Smith et al., 1986; Anderson et al., 1988; MacKinnon 
and Miller, 1988), and agitoxin acting on voltage- 
dependent K+ channels (Gross and MacKinnon, 1996). 
Recent structural work has now specifically defined the 
complex of ChTX in association with the Kv2.1 paddle-
Kv1.2 chimeric channel (Banerjee et al., 2013). Over 
the past several years, another category of naturally oc-
curring toxin has been identified that selectively targets 
voltage-sensor domains of K+ channels, inhibiting chan-
nels by stabilizing voltage-sensor domains in resting 
conformations (Swartz and MacKinnon, 1997a,b; Lee 
and MacKinnon, 2004; Milescu et al., 2009; Wang et al., 
2011). The ability of toxins to target not only specific 
ion channels but also specific functional domains of ion 
channels suggests that additional channel inhibitory 
mechanisms may remain to be revealed.
Some channel-blocking agents, for which detailed 
mechanistic information remains incomplete, have been 
termed “allosteric blockers” or “closed-channel block-
ers.” Such descriptions simply imply that a binding site 
and mechanism exist, different from direct physical 
occlusion of the permeation pathway, that maintains 
channels in nonconducting states. The voltage-sensor 
toxins, in fact, would fall in this category: they maintain 
voltage sensors in resting states, thereby allosterically 
preventing channel opening. However, in most cases 
for which a channel inhibitory mechanism has been 
termed allosteric, the specific details of how drug bind-
ing is related to channel inhibition remain unclear. 
One example of such a poorly understood allosteric 
blocking mechanism is the inhibition of BK-type K+ 
channels by the naturally occurring fungal alkaloid, 
paxilline (Knaus et al., 1994; Sanchez and McManus, 
1996; Imlach et al., 2009). The BK channel is a particu-
larly attractive target for elucidation of an allosteric 
blocking mechanism, because the well-developed frame-
work that describes allosteric regulation of BK channels 
(Horrigan and Aldrich, 2002) allows one to assess which 
part of the BK gating apparatus may be influenced by 
a compound.
Paxilline is one of a variety of fungal indole alkaloids 











Published October 27, 2014
 Zhou and Lingle 417
the control G-V curves, scaled by the fraction of unblocked chan-
nels (fun) at any given equilibration potential. For Scheme 1, 
fun(pax) = (O + C + Op)/(O + C + Op + Cp). For Scheme 2 with no 
open-blocked channels, fun(pax) = (O + C)/(O + C + Cp). For 
Scheme 3, the fraction of unblocked channels is given by: fun(pax) = 







As in previous work (Tang et al., 2009), control G-V curves were 
fit based on a standard allosteric model of BK channel activation 
































where L, K, and J represent the C-O equilibrium, Ca2+-binding 
equilibrium, and the voltage-sensor equilibrium, respectively, 
with D, C, and E representing coupling between J and L, coupling 
between K and L, and coupling between J and K, respectively. 
After definition of constants suitable to describe the control G-V 
laboratory. Experiments were performed at room temperature 
(22–25°C).
NPo measurements. For determination of NPo at negative po-
tentials, patches were pulled from oocytes expressing large num-
bers of BK channels. Openings were determined with the 
threshold-based single-channel search function of Clampfit 9, 
and total amplitude histograms were generated from the current 
records. A fit of a Gaussian function to the total amplitude histo-
grams was used to estimate NPo under various concentrations 
of paxilline.
Gating current measurements. Gating currents were recorded 
from inside-out macropatches (10–20 µM in diameter). The pi-
pette solution contained (mM):127 tetraethylammonium hy-
droxide, 125 methanesulfonic acid, 2 MgCl2, and 10 HEPES, 
pH 7.0. The internal solution contained (mM): 141 NMDG, 135 
methanesulfonic acid, 10 HEPES, and 5 EGTA, pH 7.0. Voltage 
commands were filtered at 20 kHz with an eight-pole Bessel fil-
ter (Frequency Devices) to avoid saturation by fast capacitive 
transients (Horrigan and Aldrich, 1999). Gating currents were 
filtered at 10 kHz with the internal filter of the Axopatch and 
sampled at 100 kHz. Capacitive transients and leak currents 
were subtracted using a P/5 protocol with a holding potential 
of 80 mV.
Constructs. The mSlo1 construct containing the coding region of 
mSlo1 (GenBank accession no. NM_010610; provided by L. Salkoff, 
Washington University School of Medicine, St. Louis, MO) was 
subcloned into the pXMX oocyte expression vector (Tang et al., 
2009). For experiments involving MTS reagents, the control Slo1 
construct contained the C430S mutation, which abolishes a shift 
in gating produced in WT Slo1 channels by MTS reagents (Zhang 
and Horrigan, 2005). The A313C and A316C mutations were as 
described previously (Zhou et al., 2011).
Estimates of block parameters. Both the onset of block and re-
covery from block by paxilline occur slowly, with time constants 
on the order of seconds. Furthermore, block by paxilline exhibits 
no voltage dependence during the time course of typical voltage 
steps used to define activation of conductance as a function of 
voltage. Thus, as will be more strongly developed in the Results, 
the fractional block under any condition reflects the state depen-
dence of paxilline block established at the specific holding poten-
tial and Ca2+ concentration before any change in activation 
voltage. Together, we term the particular holding potential and 
Ca2+ concentration during which paxilline block equilibrates as 
the “equilibration condition.” We consider three general schemes 
of state-dependent block. In Scheme 1, paxilline binds to both 
open and closed BK channels, but paxilline-bound open BK 
channels are able to conduct current, with inhibition resulting 
from stabilization of the paxilline-bound closed state. This corre-
sponds to allosteric regulation of the BK C-O intrinsic gating 
equilibrium, governed by coupling constant, Ep, representing the 
change in the C-O equilibrium when paxilline is bound (binding 
equilibrium constant, Kp). In Scheme 2, paxilline only binds to 
closed BK channels, thereby increasing occupancy in closed 
states. Scheme 2 is a limiting case of Scheme 1, with coupling 
constant Ep <<< 1. In Scheme 3, paxilline binds and blocks both 
open and closed BK channels. As we will establish, the paxilline-
blocking equilibrium is essentially unchanged during test se-
quences that are used to define G-V curves. Therefore, for any 
scheme, the G-V curves generated from brief test steps in the pres-
ence of paxilline will reflect only the contributions of the un-
blocked channels available at any given equilibration condition. 
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potential. Hence, for Scheme 1, where Imax reflects maximal 
activation,
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with appropriate changes to accommodate Schemes 2 and 3. For 
measurement of NPo at a fixed holding potential, only channels 
in O and paxilline-bound–open states (Op) would contribute to Po. 

































Fitting of functions to various datasets was done with a Levenberg–
Marquardt nonlinear least-squares fitting algorithm implemented 
within software developed within this laboratory. Error estimates 
for fitted parameters represent 90% confidence limits. For all 
plots, points and error bars show means ± SEM.
Chemicals. Salts and paxilline were obtained from Sigma-Aldrich. 
The details of the handling of paxilline were as described previ-
ously (Zhou et al., 2010). 20-mM stock solutions of paxilline 
were prepared in 100% DMSO and stored at 20°C. Paxilline-
containing physiological solutions were prepared the day of an 
experiment and only used up to 4 h after preparation. [2-(tri-
methylammonium)ethyl] MTS bromide (MTSET), 2-aminoethyl 
MTS (MTSEA), and sodium (2-sulfanoethyl) MTS (MTSES) were 
obtained from Toronto Research Chemicals.
R E S U L T S
BK current that gates during partial inhibition by paxilline 
is indistinguishable from BK current in the absence  
of paxilline
Previous reports have suggested that paxilline may alter 
BK G-V curves (Sanchez and McManus, 1996), although 
this has not been a consistent feature of paxilline action 
or that of related alkaloids (Imlach et al., 2009, 2011; 
Zhou et al., 2010). A shift in the G-V curve in the pres-
ence of paxilline would suggest that part of paxilline 
inhibition of BK channels arises from alteration in the 
BK gating equilibrium during the time of test steps. Be-
cause of the challenges posed by slowly acting and slowly 
reversible blocking drugs, we confined our compari-
sons to patches in which complete recovery from paxil-
line inhibition could be achieved. In such cases, we 
observed that G-V curves generated from BK channels 
curves, these parameters were then constrained, while parame-
ters for blocking schemes were defined.
Given that no changes in the paxilline-blocking equilibrium 
occur during the duration of voltage steps used to test BK activa-
tion, the predicted dependence of the G-V curve for any scheme 
in the presence of paxilline will be given by
 G V
L




With the paxilline affinity to the closed channel given by Kp, the 
open-state affinity, Kp(o), is Kp/Ep. For Scheme 1, in which the bind-
ing of paxilline allosterically regulates the C-O equilibrium con-
stant, L, favoring stabilization of closed states, open channels, 
although able to bind paxilline, remain conducting with:































where L hp( ) is as defined above but for the equilibrium conditions 
defined by the holding potential. Scheme 2, in which paxilline 
does not bind to open channels, is described by Eq. 1 with Ep = 0, 
such that:
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For Scheme 3, in which paxilline can bind to both open and 



























Eqs. 1–3 all assume binding of a single paxilline molecule per 
channel. The possibility that inhibition may be associated with 
binding of multiple paxilline molecules will be considered in the 
Results. Under various limiting conditions, some schemes be-
come equivalent. For example, when Ep << 1 (i.e., Kp <<< Kp(o), all 
three schemes are essentially identical. Furthermore, in Scheme 3, 
by fixing closed-channel block to very weak binding affinity, Eq. 3 
defines fractional unblock in accordance with a standard open-
channel block model. The use of the H-A formulation to describe 
activation is not critical for evaluating paxilline effects on the G-V 
curves, as a simple Boltzmann description of activation would also 
suffice. However, the H-A formulation becomes useful when si-
multaneously fitting inhibition by paxilline over multiple activa-
tion conditions (e.g., Figs. 6 E and 7).
For fitting of fractional inhibition by paxilline across multiple 
conditions, Eqs. 1–3 were adapted in the following way. Under 
different holding conditions of voltage and Ca2+, the application 
of paxilline results in some defined reduction of current, reflect-
ing equilibration of channels into nonactivatable, paxilline-
bound states. The test steps to positive voltages are then assumed, 
for Scheme 1, to result in the opening of all channels not in 
closed-paxilline–bound states. Thus, channels simply in closed 
states will be activated during the brief test steps. The fraction of 
unblocked channels at any condition, fun(Ca2+, V, [Pax]), is there-
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in inside-out patches studied with symmetrical K+ solu-
tions exhibit no clear shift in the voltage of half-activa-
tion during applications of paxilline at concentrations 
producing >50% inhibition (Fig. 1, A and B). Because 
of concern that slow gating shifts, perhaps redox depen-
dent (DiChiara and Reinhart, 1997), might appear to 
underlie a change during prolonged paxilline applica-
tion, we also examined the effect of paxilline on G-V 
curves in the constant presence of dithiothreitol (Fig. 1, 
C and D) without observing any effect. Thus, those BK 
channels that are activated during brief activation steps 
in the presence of paxilline appear to open and close 
with normal voltage and Ca2+ dependence. In the Dis-
cussion, we point out reasons why apparent shifts in G-V 
curves might be observed under some conditions based 
on the features of the paxilline inhibitory mechanism 
described here.
During the wash-in and wash-out of paxilline, both 
inhibition (Fig. 1 E) and removal of inhibition (Fig. 1 F) 
develop over tens of seconds, despite the use of a solu-
tion exchange system in which blockade and recovery 
from inhibition by quaternary ammonium blockers is 
complete within a few seconds or hundreds of millisec-
onds (e.g., see Fig. 12). Although it is possible that a 
slow equilibration of the paxilline concentration at the 
site of inhibition may contribute to the slow kinetics, it 
seems likely that the molecular steps involved in the de-
velopment and recovery from paxilline inhibition are 
themselves slow (as will be addressed further below). 
Under such a situation, once a particular blocking equi-
librium is established at a given holding condition, brief 
changes in membrane potential (as in the generation of 
a G-V curve) would not be expected to appreciably alter 
the overall block equilibrium. Therefore, although pax-
illine inhibition does depend inversely on channel Po 
(see below), under all conditions both the onset and 
recovery from paxilline inhibition is sufficiently slow, 
such that brief depolarizations of a few tens of millisec-
onds will not alter the paxilline block equilibrium estab-
lished at a given holding condition. As an additional 
evaluation of the properties of channels activated in the 
presence of paxilline, we compared the activation and 
deactivation time course of BK currents in the absence 
Figure 1. Channels that activate in the presence of paxilline gate 
with normal voltage dependence and kinetics. (A) G-V curves 
were normalized to the maximal conductance observed in con-
trol saline. Currents were activated with 10 µM cytosolic Ca2+ from 
a holding potential of 0 mV. For prepaxilline, Vh = 16.31 ± 0.15 mV 
(z = 0.87 ± 0.01 e); in 100 nM paxilline, Vh = 24.75 ± 0.13 mV 
(z = 0.86 ± 0.01 e); and, after washout of paxilline, Vh = 28.0 ± 
0.19 mV (z = 0.88 ± 0.01 e). (B) G-V curves from A were normalized 
to the fitted maximum for each condition to highlight the lack of 
G-V shift. (C) G-V curves were generated in the presence and ab-
sence of paxilline, but with all solutions containing 10 mM DTT 
(n = 7 patches). For control saline, Vh = 25.04 ± 1.2 mV (z = 0.86 ± 
0.06 e); with 50 nM paxilline, Vh = 21.21 ± 1.85 (z = 0.79 ± 0.07 e); 
and after wash, Vh = 28.65 ± 9.0 (z =1.13 ± 0.05 e). (D) The same 
G-V curves in C are normalized to the maximal conductance in 
each case to highlight their similarity. (E) 2-ms steps to 160 mV 
were applied at 0.2 Hz to monitor BK activation with 300 µM Ca2+, 
while holding the patch at 80 mV. The application of 100 nM 
paxilline results in slow diminution of BK current with a time con-
stant (fitted red line) of 9.6 ± 1.1 s. (F) For the same patches as 
in E, steps to 160 mV with 300 µM Ca2+ were used to monitor 
recovery from paxilline inhibition, with recovery at 300 µM Ca2+ 
at 80 mV with the indicated recovery time constant (red line). 
(G) For a single patch, BK current activation (closed circles) was 
monitored at 160 mV and deactivation (open circles) at 80 mV 
with 300 µM Ca2+ before and during the application of 20 nM pax-
illine, showing that paxilline does not alter the kinetics of chan-
nels that open and close in the presence of paxilline. (H) A patch 
was held at 0 mV and 500 nM paxilline was applied at either of 
two different Ca2+ concentrations (10 or 100 µM). The onset of 












Published October 27, 2014
420 Paxilline stabilizes closed states of BK channels
by paxilline on BK channels held under three differ-
ent equilibration conditions differing in Po: (1) 0 mV, 
10 µM Ca2+ (Po of 0.02); (2) 70 mV, 300 µM Ca2+ 
(Po of 0.07); (3) 0 mV, 300 µM Ca2+ (Po of 0.48). 
G-V curves were generated for each equilibration con-
dition for control solutions and in both 10 and 100 nM 
paxilline. For this set of patches, each patch was exam-
ined under all three conditions. In each case, paxilline 
was applied for 4 min to allow equilibration before 
generation of curves. Recovery from any individual ap-
plication of paxilline was at least 90%. For the condi-
tion of lowest resting Po (Po of <0.02; 0 mV, 10 µM 
Ca2+), 10 nM paxilline blocked over half the current 
activated at each voltage, whereas 100 nM paxilline 
produced essentially complete inhibition (Fig. 2 A). 
Changing the equilibration condition to 300 µM Ca2+ 
at 0 mV (Po of 0.48; Fig. 2 B) resulted in a marked 
reduction in the effectiveness of paxilline inhibition at 
both 10 and 100 nM, consistent with the idea that ele-
vation of [Ca2+] diminishes paxilline block. However, 
when the equilibration condition was changed to 70 mV 
with 300 µM Ca2+ (Po of 0.07; Fig. 2 C), paxilline in-
hibition returned to levels more similar to those ob-
tained with 10 µM Ca2+ at 0 mV (Fig. 2 A). These results 
suggest that inhibition by paxilline may not be reduced 
by increases in Ca2+ per se, but by increases in channel 
Po. Specifically, paxilline inhibition is inversely related 
to the BK channel Po at the equilibration condition 
under which paxilline is applied (Fig. 2 D). This inverse 
relationship between BK Po and inhibition by paxil-
line immediately excludes the simple case that paxil-
line exclusively blocks open channels.
of paxilline and during development of inhibition by 
paxilline (Fig. 1 G). As inhibition by paxilline develops, 
neither the activation nor deactivation time constant 
is altered.
Collectively, these initial tests establish a few features 
of paxilline inhibition critical to evaluation of later ex-
periments. First, the results show that the BK current 
that persists during partial inhibition by paxilline gate 
normally. Second, these results are consistent with the 
suggestion (Zhou et al., 2010) that the fractional inhibi-
tion by paxilline reflects inhibition established at the 
holding condition or equilibration conditions of the 
experiment (i.e., voltage and Ca2+). Channels inhibited 
by paxilline simply do not contribute to the observed 
currents, and brief depolarizing steps do not result in 
changes in the paxilline block equilibrium.
Prompted by earlier results (Sanchez and McManus, 
1996) indicating that inhibition of BK channels by pax-
illine is reduced by elevations in Ca2+, we also examined 
the onset and/or recovery of paxilline inhibition with 
either 10 or 100 µM Ca2+ while holding a patch at 0 mV. 
The onset of block by 500 nM paxilline was faster and 
recovery was slower with 10 µM Ca2+ compared with 
100 µM Ca2+ (Fig. 1 H), qualitatively consistent with 
the earlier observations (Sanchez and McManus, 1996). 
This result prompted a more detailed examination of 
the conditions that influence paxilline inhibition pre-
sented below.
Inhibition by paxilline varies inversely with steady-state 
channel Po at the equilibrium condition
To explore further the dependence of paxilline inhibi-
tion on Ca2+, we examined the fractional block produced 
Figure 2. Block by paxilline exhibits an inverse depen-
dence on Po, but no dependence on Ca2+ per se. G-V 
curves were generated under three equilibration con-
ditions (A: 10 µM Ca2+, 0 mV; B: 300 µM Ca2+, 0 mV; 
C: 300 µM, 70 mV), with either control saline or either 
of two paxilline concentrations, 10 or 100 nM. For all 
patches included in this dataset, each patch was ex-
amined under all conditions. Paxilline was applied for 
4 min before generation of G-V curves. Among differ-
ent patches, the sequence of holding conditions was 
varied. G-V curves were normalized to the maximal con-
ductance observed in the absence of paxilline under 
each holding condition. Curves to control points are 
fitted single Boltzmann functions, whereas curves in 
the presence of paxilline have no significance. (D) The 
fractional block for voltages from 40 to 120 mV was de-
termined for each paxilline application under the three 
conditions and plotted in relation to the Po at the holding 
condition defined by the fitted Boltzmann. For 10 µM 
Ca2+ and 0 mV, the effective Po was 0.02; for 300 µM 
and 70 mV, the Po was 0.07; and for 300 µM Ca2+ and 
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The weak inhibition by paxilline of BK currents held 
at positive holding potentials with elevated Ca2+ was also 
tested in a set of patches in which only a single BK chan-
nel was expressed. Patches were held either at 70 or 
70 mV with 300 µM Ca2+. In one such patch (Fig. 3 D), 
after the establishment of a given equilibration condi-
tion (>45 s), channel activity was monitored first with a 
500-msec period at 70 mV and then a 500-msec period 
at 70 mV, separated by 50 ms at 0 mV (Fig. 3 D, 1). After 
development of inhibition by 100 nM paxilline at 70 mV, 
subsequent test steps show essentially no channel activa-
tion at either 70 or 70 mV (Fig. 3 D, 2). After return 
to a holding potential of 70 mV while still in the pres-
ence of 100 nM paxilline, channel activity similar to the 
control behavior was restored at both 70 and 70 mV 
(Fig. 3 D, 3). Thus, even in the constant presence of 
paxilline, channels can recover from inhibition at con-
ditions of high Po. After returning the holding poten-
tial to 70 mV (while still in the presence of paxilline), 
complete inhibition was reestablished (Fig. 3 D, 4). Fi-
nally, after washout of paxilline while holding at 70 mV, 
channel activity was restored (Fig. 3 D, 5). Subsequent 
wash-in of paxilline while holding at 70 mV failed to 
We next examined the inhibition produced by 100 nM 
paxilline over holding potentials from 80 to 80 mV 
with constant 300 µM Ca2+, with unblocked current mon-
itored by brief depolarizing steps to 160 mV (Fig. 3 A). 
Paxilline was washed out between tests at different hold-
ing potentials. At holding potentials of 80 and 40 mV, 
the application of 100 nM paxilline resulted in a 
similar onset and extent of inhibition (Fig. 3 B). At 0 mV, 
paxilline inhibition was slower and incomplete, whereas 
at 80 mV, paxilline produced almost no inhibition over 
1 min of application. At the most positive holding po-
tentials in this experiment (40 and 80 mV), the steady-
state conductance activated by steps to 160 mV was 
reduced relative to that at more negative holding po-
tentials. This reflects a very slow inactivation behavior 
often observed for BK channels activated with strong 
depolarizations and elevated Ca2+ (Fig. 3 C), and does 
not appear to be related to paxilline inhibition. Overall, 
this result further supports the view that paxilline block 
is markedly reduced under conditions favoring open 
BK channels, whether from elevations in Ca2+ or depo-
larization. Remarkably, paxilline has almost no inhibi-
tory effect under conditions near maximal BK Po.
Figure 3. Paxilline inhibits chan-
nels at conditions of low Po, but 
not under conditions of high Po. 
(A) An inside-out patch bathed 
with 300 µM Ca2+ was initially held 
at 80 mV. The patch potential was 
then stepped to holding potentials 
of 40, 0, 40, and 80 mV (from left 
to right), and 1.6-ms steps to 160 mV 
were used to monitor available BK 
current, while 100 nM paxilline was 
applied after the 10th step at a 
given holding potential. Paxilline 
was washed out and full recovery 
from block was obtained between 
tests at different holding potentials. 
At the most negative potentials, 
block is substantial, whereas at 40 
and 0 mV, there is little develop-
ment of block. (B) The peak out-
ward current from the traces in A 
is plotted as a function of elapsed 
experimental time. (C) The time 
course of reduction of current 
during sustained depolarization to 
80 mV is shown, establishing that 
the reduction of current at the pos-
itive holding potentials (B) does 
not reflect paxilline block, but an 
intrinsic slow reduction in BK con-
ductance with prolonged depolar-
ization. (D) All traces are from the 
same single-channel patch, stimulated with the protocol shown on the top. The patch was constantly exposed to 300 µM cytosolic Ca2+. 
(1) Control activity in the absence of paxilline. (2) The holding potential was changed to 70 mV, and 100 nM paxilline was applied. 
The trace was taken after 30 s in paxilline. (3) The trace was taken 30 s after the patch had been returned to 70 mV while in the 
constant presence of 100 nM paxilline. (4) The trace was taken 30 s after the patch was again returned to 70 mV while in paxilline. 
(5) The trace was obtained after washout of paxilline while holding the patch at 70 mV. (6) The trace was taken 30 s after 100 nM 
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that paxilline alters the C-O equilibrium, in essence re-
ducing the equilibrium constant, L. Patches with a large 
number of channels were therefore used to obtain esti-
mates of NPo at 80 mV, both at 10 and 300 µM Ca2+ 
(for 300 µM Ca2+, see Fig. 5 A) alone and then with dif-
ferent paxilline concentrations. The NPo in the pres-
ence of paxilline was then normalized to the NPo 
measured for that patch in the absence of paxilline 
(Fig. 5 B). Paxilline inhibited the BK current by >95% 
at 100 nM paxilline, both in 10 and 300 µM Ca2+. Be-
cause the results above suggest that the effects of paxil-
line on open states are minimal, the reduction of NPo 
at negative potentials suggests that paxilline markedly 
restore inhibition (Fig. 3 D, 6). It is noteworthy that 
during inhibition by paxilline, no openings are observed 
at all during these brief 500-ms periods at either 70 or 
70 mV (Fig. 3 D, 2 and 4). Thus, several 100 ms are not 
sufficient to allow recovery from paxilline inhibition, 
even at conditions favoring high Po. However, when the 
test sequence is applied after equilibration in paxilline 
at 70 mV, BK openings still occur intermittently during 
the entire 500 ms at 70 mV (Fig. 3 D, 3). This is gener-
ally consistent with the earlier results (Fig. 1 E), indicat-
ing that the onset of paxilline inhibition develops over 
several seconds.
The ability of inhibition by paxilline to be reversed 
by changes in equilibration conditions, even in the 
constant presence of paxilline, was also confirmed in 
patches with large numbers of BK channels (Fig. 4). 
Specifically, after onset of block in 100 nM paxilline 
(Fig. 4 A), changing the equilibration conditions to 
those favoring unblocking can produce recovery from 
paxilline inhibition (Fig. 4, B and C). It may be noticed 
that the onset of paxilline inhibition appears variable 
during wash-in of paxilline. This is addressed below and 
appears to reflect variability in paxilline access to the 
patch, despite the rapidity of solution exchange with small 
charged molecules.
These tests show clearly that inhibition of BK channels 
by paxilline is reduced or even absent under condi-
tions favoring high Po, whether produced by depolari-
zation or by Ca2+. Qualitatively, the relief of inhibition 
at high Po suggests either that: (a) if paxilline binds 
with nanomolar affinity to the open state, it must not 
occlude permeation; or (b) if paxilline can occlude per-
meation, it must only bind very weakly to the open state. 
Most importantly, it suggests that effects on the open 
state are not central to inhibition by paxilline.
Paxilline inhibits BK NPo under conditions where voltage 
sensors are largely inactive
Paxilline might favor occupancy of channels in closed 
states, perhaps without directly occluding the ion per-
meation pathway, by a variety of mechanisms. In one, 
the binding of paxilline may alter the C-O equilibrium 
constant, L, favoring occupancy of closed states. In an-
other, paxilline may stabilize the BK voltage sensors in 
resting states. A third possibility, that paxilline disrupts 
the linkage of Ca2+ binding to gating, seems unlikely, as 
increases in Ca2+ reduce paxilline inhibition.
At negative potentials where voltage sensors are largely 
inactive, BK channels open at low Po, even in the ab-
sence of Ca2+ in accordance with the intrinsic equilib-
rium (L) between unliganded closed and unliganded 
open channels (Horrigan and Aldrich, 2002). Under 
such conditions, increases in cytosolic Ca2+ favor addi-
tional BK channel activation (Horrigan and Aldrich, 
2002). If paxilline is able to reduce NPo when voltage 
sensors are largely inactive, it would support the possibility 
Figure 4. Essentially complete recovery from paxilline block can 
occur, even in the continuous presence of paxilline under condi-
tions of high Po. (A) The indicated test-pulse sequence was ap-
plied every 1 s while holding at 80 mV with 300 µM Ca2+. The 
traces show before paxilline application, after 50% inhibition 
by paxilline, and during the full paxilline effect. (B) For the same 
patch in A, the equilibration conditions were altered to 80 mV 
with 300 µM Ca2+ while still in the continuous presence of 100 nM 
paxilline. Brief sojourns to 80 mV with test steps to 160 mV were 
used to monitor recovery in the presence of paxilline. A 60-s wash-
out of paxilline confirmed that no additional recovery occurred. 
(C) The time course of onset and recovery from inhibition by 
100 nM paxilline, while in the continuous presence of paxilline, 
is plotted for the cell shown in A and B, with the numbers cor-
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result indicates that the binding of paxilline produces a 
>95% inhibition of BK Po under conditions in which 
voltage sensors are largely inactive and Po is defined 
largely by the intrinsic C-O equilibrium.
To evaluate whether the effects of paxilline are inde-
pendent of any effect on voltage sensors, we measured 
gating currents in patches containing large numbers of 
channels, both in the absence and then in the pres-
ence of 500 nM paxilline (Fig. 5 C). The gating current 
associated with activation steps (Qon) was determined 
over a range of activation voltages and normalized to 
the fitted Qon(max) defined from a simple Boltzmann 
(Fig. 5 D). The Qon versus command potential relation-
ship was essentially identical in the absence and pres-
ence of 500 nM paxilline. Qoff was also determined 
in the presence and absence of paxilline (Fig. 5 E). 
Although any effect of paxilline on Qoff is small, the 
duration of the activation step preceding the off-step is 
likely to have been sufficient to have caused some chan-
nels to open in the absence of paxilline, while less 
likely to have opened in the presence of paxilline. Thus, 
the Qoff relationship in paxilline likely reflects solely 
equilibration of voltage sensors among closed states, 
whereas in the absence of paxilline, there may be con-
tributions of voltage sensors, as some channels pass 
from open to closed states. Regardless of the origins of 
the slight difference observed in Qoff, the results pro-
vide strong support for the idea that paxilline does not 
alter the voltage-sensor equilibrium nor impede voltage- 
sensor movement.
Inhibition of BK current is best explained by binding  
to and stabilization of closed states
100 nM paxilline reduced the normalized NPo to <0.05 
at 80 mV and 300 µM Ca2+. This is consistent with 
a mechanism in which binding of paxilline reduces 
the intrinsic O/C ratio by >0.05, favoring occupancy of 
closed channels. However, the data do not distinguish 
among different models of block involving closed- 
channel stabilization. The recognition that unblock 
from paxilline can be facilitated by high Po conditions 
prompted us to pursue a more extensive examination 
of the paxilline concentration dependence under dif-
ferent equilibration conditions. We therefore examined 
the concentration dependence of paxilline inhibition 
over a range of equilibration conditions that span a 
wide range of BK Po. Specifically, paxilline inhibition 
was examined with equilibration conditions of 300 µM 
Ca2+ at 70 mV (Fig. 6, A and C), 0 mV, 40 mV (Fig. 6, 
B and D), and 70 mV. For the set of patches used in 
this experiment, these equilibration conditions corre-
sponded to effective Po’s of 0.1, 0.65, 0.83, and 
0.89. For each equilibration condition, fractional in-
hibition was determined for at least four different paxil-
line concentrations (Fig. 6, A–D). To monitor block 
under each of these conditions, brief 2-ms test steps to 
increases the fraction of time a channel is closed. A fit 
of a simple Hill function (see legend to Fig. 5) to the 
paxilline-induced reduction in normalized NPo yielded 
an IC50 for inhibition of 5.0 ± 1.5 nM with n = 0.85 ± 
0.25, with n = 1 clearly better than n = 2 (Fig. 5 B). This 
Figure 5. Paxilline reduces NPo at conditions where voltage sen-
sors are largely inactive, and does not influence the voltage-sensor 
equilibrium. (A; top) The trace shows example channel activity at 
80 mV and 300 µM Ca2+ for a macropatch with many channels. 
4-ms steps to 100 mV (not depicted) were also used to monitor 
paxilline inhibition. (Middle and bottom) These traces show ac-
tivity under the same conditions but with 5 and 100 nM paxilline, 
respectively. NPo was determined from activity at 80 mV. 
(B) The NPo measured in paxilline for 3 s of activity normalized 
by the NPo measured in the absence of paxilline is plotted as a 















with IC50 = 5.5 ± 1.1 nM with n = 1. Red dotted line corresponds to 
a fit of the same function with n = 2. (C) Gating currents mea-
sured with an activation step to 160 mV from 80 mV with 0 µM 
Ca2+ are shown in the absence and presence of 500 nM paxilline. 
(D) The Qon integrated over 1 ms for steps to the indicated poten-
tials are plotted for control and 500-nM paxilline solutions. Fitted 
lines correspond to: without paxilline, z = 0.56 ± 0.050 e with Vh = 
137.6 ± 14.3 mV; with paxilline, z = 0.54 ± 0.025 e with Vh = 131.4 ± 
2.1 mV. (E) Qoff is plotted as a function of previous command 
potential for 0 and 500 nM paxilline. Without paxilline, z = 0.66 ± 
0.07 e with Vh = 142.7 ± 14.3 mV; with paxilline, z = 0.56 ± 0.035 e 
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paxilline application. To minimize uncertainties aris-
ing from cumulative inhibition, at the highest Po con-
dition patches were only used for one to two paxilline 
applications (e.g., Fig. 6, B and D). Consistent with 
earlier experiments, the concentrations of paxilline 
required to produce inhibition at conditions of high 
Po were orders of magnitude higher than those re-
quired at lowest Po.
From this type of experiment, the fractional inhi-
bition by paxilline shifts markedly rightward as the 
equilibration conditions result in channels of higher Po 
(Fig. 6 E). If one fits a simple Hill equation through the 
plot of fractional unblock as a function of [paxilline] 
under each equilibration condition (Fig. 6 E, red dot-
ted lines), the apparent IC50 for paxilline inhibition 
160 were used, which do not alter the fraction of chan-
nels blocked by paxilline. Current activated by the brief 
test steps corresponds to that fraction of channels in all 
unblocked states at the equilibration conditions. For 
paxilline application under conditions of highest Po 
(either 40 or 80 mV at 300 µM Ca2+), the slow onset of 
inhibition posed challenges to a direct determination 
of steady-state inhibition. In such cases, a fit of a single 
exponential to the onset of block (Fig. 6 D) was used to 
obtain an extrapolated estimate of fractional inhibi-
tion. Furthermore, despite the ability of high Po to re-
duce inhibition by paxilline, at the highest paxilline 
concentrations full wash-out was difficult to achieve, 
perhaps because of accumulation of paxilline within 
the recording pipette during the long durations of 
Figure 6. Concentration dependence of paxilline 
inhibition at four different conditions of channel 
Po. (A) Traces show currents activated by brief steps 
to 160 mV under equilibration conditions of 70 mV 
and 300 µM Ca2+ with 5, 20, 50, and 200 nM paxil-
line. Red line shows the identical level of peak cur-
rent for each paxilline test. (B) Traces show currents 
activated by steps to 160 mV under equilibration 
conditions of 40 mV and 300 µM Ca2+ for 200 nM, 
500 nM, and 5 µM paxilline, all from the same patch. 
(C) The onset of inhibition of current activated at 
160 mV with 300 µM Ca2+ at 70-mV equilibration 
condition from traces as in A is shown for five pax-
illine concentrations along with single-exponential 
fits (red). (D) Onset of inhibition with single-expo-
nential fits (red) is shown for the higher Po equilib-
rium condition (B). (E) The fraction of unblocked 
BK current is plotted as a function of paxilline for 
four different equilibration conditions (70, 0, 40, 
and 70 mV, all with 300 µM Ca2+) from experiments 
as in A and B. Dotted red lines correspond to fits of a 
Hill function, with IC50 values of 11.7 ± 1.9 nM, 58.4 ± 
2.9 nM, 469.8 ± 94.9 nM, and 5.37 ± 1.0 µM, from left 
to right. Solid lines correspond to the fit of Scheme 1, 
with Kp = 11.85 nM and Ep = 0.002, with n = 1.09. 
(F) The inhibition of NPo at 80 mV and either 10 
or 300 µM Ca2+ is displayed from Fig. 5 B, with the 
dotted red line corresponding to the best fit from 
Scheme 1 (E) (Kp = 11.85 nM). (G) IC50s from E are 
plotted as a function of O/C and fit with log(IC50) = 
m(O/C) + log(Kcp), where m (0.33 ± 0.02) is the 
slope of the relationship and Kp (12.1 ± 1.1 nM) is 
the extrapolated IC50 with all channels closed. This 
provides a model-independent estimate of paxilline 
inhibition of closed channels. (H) IC50 estimates are 
replotted as a function of Po along with the fit in F. 
The extrapolation of the line to Po of 1 provides a 
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paxilline molecule produces the inhibitory effect. This 
model also assumes that the binding of paxilline to the 
open state does not block conductance. An interesting 
feature of this model is the tendency toward flattening of 
the predicted block curves at <100% block at the highest 
paxilline concentrations. Although this estimate of Kp is 
somewhat greater than estimated in the measurements 
of paxilline inhibition under conditions of inactive volt-
age sensors (Fig. 5, A–C), the fitted value of Scheme 1 for 
the low Po situation provides a satisfactory approxima-
tion of the reductions of NPo (Fig. 6 F). The suitability of 
this model and other models will be addressed in more 
detail below.
shifts from 11.7 nM, 58.4 nM, 469.8 nM, to 5.3 µM over 
the equilibration conditions of 70, 0, 40, and 70 mV 
all at 300 µM Ca2+. This provides additional strong sup-
port for the unusual state dependence of paxilline in-
hibition, with inhibition being much more strongly 
favored under conditions of low Po. If we assume that 
the effect of paxilline arises solely from an alteration 
in the C-O equilibrium constant, L(0) as defined in 
Scheme 1, a fit of this model (Eq. 1) yields Kp = 11.9 ± 
2.3 nM, with n = 1.09 ± 0.11 and Ep of 0.002 (Fig. 6 E, 
black lines). This dataset and model imply that the bind-
ing of paxilline to the open channel is 500-fold weaker 
than the binding to closed channels, and that a single 
Figure 7. Paxilline stabilizes closed states with only weak, if any, binding to open states. (A) Curves of concentration-dependent inhibi-
tion of BK current at four equilibration conditions were fit with Scheme 1, with the assumption that the current activated at positive 
potentials reflects channels initially either in C, O, or OB, i.e., any open channels with bound paxilline are conducting. Each panel 
from left to right corresponds to fits with Scheme 1 (Eq. 7) in which either one, two, or four paxilline molecules can bind to inhibitory 
positions. Best-fit values are given in the figure. The model with n = 1 best accounts for the shape of the inhibition by paxilline. (B; left) 
Scheme 1 was again used, while constraining Ep to 0.01 (left), 0.1 (middle), or 1.0 (right), showing that increasing open-state affinity 
fails to account for the data. Right-hand panel corresponds to state-independent paxilline interaction with C and O. (C) Ep was set to 0, 
thereby approximating strictly closed-channel block. (D) Data were fit with Scheme 3 (Eq. 3) in which the paxilline-bound open state 
is nonconducting. On the left, the value for Ep drifted toward 0, similar to a strictly closed-channel block situation. On the right, Ep was 
set to 1 (state-independent binding of paxilline). SSQN in A and C corresponds to the sum-of-squares for a given fit normalized to the 
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in closed- and open-state affinity (Ep = 0.01), the result-
ing fit is completely inadequate, again supporting the 
view that paxilline exerts a very strong effect on the C-O 
equilibrium. The case in which Ep = 1 (Fig. 7 B, right) 
corresponds to a completely state-independent form of 
Scheme 1. In this case, inhibition is absent for the 
higher Po conditions, even at maximal [paxilline], as 
both O and Op are conducting states.
Do the results permit us to exclude other models? 
The value of Ep estimated from the fit of Scheme 1 im-
mediately suggests that the dataset is unlikely to strongly 
distinguish among the different models. To evaluate 
this directly, we first fit the paxilline concentration de-
pendence of inhibition with Scheme 2 (Fig. 7 C; closed-
state inhibition alone; Eq. 2). This results in an adequate 
fit of the data, although not as good as with Scheme 1. 
With Scheme 3 (both closed and open states can be 
inhibited by paxilline; Eq. 3), convergence was only 
achieved when Ep was set to very small values, essentially 
making it identical to closed-channel block (Fig. 7 D). 
A state-independent form (Ep = 1) of Scheme 3 illustrates 
that, under all conditions of Po, inhibition by paxilline 
would be identical.
These results strongly support the idea that the bind-
ing of a paxilline molecule to a BK channel strongly 
stabilizes closed states, corresponding to a >500-fold 
reduction in the C-O equilibrium constant, L(0). Fur-
thermore, the analysis suggests that only one paxilline 
molecule can act on a BK channel at a time. Can we 
exclude the possibility that paxilline does not bind to 
open channels at all? Thermodynamically, that is un-
likely. Although the optimal fit was achieved for Scheme 1, 
the differences among Fig. 7 A (left), Fig. 7 C, and 
Fig. 7 D arise largely from the data points at 300 µM 
Ca2+, 70 mV, at the highest paxilline concentrations. 
Both Schemes 2 and 3 predict stronger block and es-
sentially complete block at the highest concentrations, 
whereas Scheme 1 predicts some finite current at the 
highest paxilline concentrations, as open paxilline-
bound channels are conducting. Unfortunately, it is the 
estimates of fractional inhibition at 5 and 20 µM paxil-
line that are the most technically challenging and prob-
ably most subject to errors, as fractional block was often 
estimated from extrapolation of a fitted exponential. 
Yet, despite this uncertainty, the key point is that paxil-
line affinity between closed and open states differs 
markedly. In fact, for all practical purposes, for condi-
tions under which paxilline is typically used to inhibit 
BK channels, only closed-channel binding and stabiliza-
tion are relevant.
Kinetics of onset of paxilline inhibition
An examination of the kinetics of the onset and recov-
ery from paxilline inhibition and dependence on paxil-
line concentration may help provide additional insight 
into mechanism. However, as noted in regards to Fig. 1 E, 
Another way of viewing the inhibition by paxilline is to 
plot the nominal IC50 (estimated from the fit of NPo(pax)/
NPo(max) = 1/(1 + [PAX]/IC50) relative to state occu-
pancy. Specifically, a plot of IC50 versus Po/(1  Po) 
(Fig. 6 G) provides some largely model-independent 
conclusions about paxilline action. Empirically, log(IC50) 
varies linearly with Po/(1  Po) over a broad range of 
closed-state occupancies. At the limit of maximal C-state 
occupancy, for this set of data the limiting IC50 is 12.1 ± 
1.1 nM, which essentially provides a model-independent 
estimate of the closed-state affinity for paxilline (Fig. 6 G). 
As C-state occupancy decreases, IC50 changes almost 
1,000-fold, implying that if paxilline binds to and inhibits 
open states, it must do so at an affinity almost 1,000-fold 
weaker than binding to the closed states. The lack of 
horizontal asymptote in the relationship between IC50 as 
a function of Po (Fig. 6 H) also strongly suggests that the 
open state is not directly inhibited at concentrations up 
to 10 µM.
Allosteric regulation of the C-O equilibrium constant, L, 
best explains paxilline action
Although Scheme 1 yielded a very satisfactory fit of the 
reduction of current as a function of paxilline, we next 
assessed whether other variations of Scheme 1 or other 
schemes that include closed-channel block would also be 
consistent with the data. First, we compared the extent to 
which the quality of the fit with Scheme 1 was dependent 
on whether one, two, or four paxilline molecules could 
all occupy inhibitory positions. Eq. 1 was modified (Eq. 7) 
to reflect up to n paxilline-binding sites, where each site 
independently influences the C-O equilibrium. This is 
analogous to the regulation of L by Ca2+ (Horrigan and 
Aldrich, 2002), except that instead of increasing BK acti-
vation, activation is inhibited.














































When paxilline inhibition is assumed to involve two 
or four independent sites, the resulting fits do a less ad-
equate job of approximating the data compared with a 
single paxilline-binding site (Fig. 7 A). This therefore 
suggests that, wherever the site of paxilline action within 
the BK tetramer, a channel can probably only accom-
modate a single paxilline molecule.
Both the model-independent analysis in Fig. 6 and 
the fit of Scheme 1 to the concentration dependence of 
paxilline inhibition (Fig. 7 A) indicate a nearly 1,000-
fold difference between paxilline affinity between closed 
and open states. We next compared the consequence of 
assuming a smaller difference in affinity (Ep = 0.01, 0.1, or 
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and also from changes in equilibration conditions in 
the same set of patches (Fig. 8). For this set of four 
patches, the onset of inhibition by simple wash-in of 
100 nM paxilline at 80 mV with 300 µM Ca2+ occurred 
with a time constant of on of 26.3 ± 6.6 s (mean ± STD). 
In contrast, after establishing a steady-state unblocked 
(Fig. 8 A; 80 mV; 100 nM paxilline) condition, the hold-
ing potential was changed to promote block (Fig. 8 A; 
80 mV). In this case, the onset of paxilline inhibition 
(80 mV, 300 µM Ca2+) developed with a time constant 
of 6.85 ± 1.79 s, about fourfold faster than that observed 
with paxilline wash-in (Fig. 8 A). The variance of esti-
mates obtained from paxilline wash-in was significantly 
greater (F-test) than that from estimates derived from 
changes in equilibration conditions. Although our so-
lution-exchange system generally allows for complete 
exchange of readily soluble molecules within a few hun-
dred milliseconds (e.g., Fig. 14 A), we suspect that the 
slow onset of paxilline inhibition during wash-in may be 
influenced by a slow increase in paxilline concentration 
within the omega of the inside-out patch, given the ten-
dency of paxilline to stick to or partition into any avail-
able hydrophobic surface–including membranes.
The variability and slower onset of inhibition that 
occurs with direct paxilline perfusion suggests that 
wash-in is not a useful method for assessing kinetic aspects 
of paxilline inhibition. However, the kinetics of block 
onset, while in the continuous presence of paxilline, is 
likely to represent some intrinsic kinetic step in the pax-
illine inhibitory equilibrium. We therefore measured 
the onset of paxilline inhibition under a more extensive 
set of conditions. First, after equilibration with 100 nM 
paxilline at 80 mV and 300 µM Ca2+, during which no 
inhibition was observed, we then examined the onset of 
paxilline inhibition at potentials from 20 mV to 60 mV 
(Fig. 9, A and B), using a protocol identical to that used 
in Fig. 8 A. The rate of inhibition varied over 20-fold 
from 20 to 60 mV (Fig. 9, B and D). The onset of inhi-
bition was reasonably well fit with a single-exponential 
function, but at some conditions of intermediate closed 
probability (Pc), a double-exponential function yielded 
a clearly superior fit (Fig. 9 C), with the resulting sum-
of-squares improved four- to fivefold. The rate of block 
was plotted as a function of Pc, the probability of being 
closed, using the mean rate from fits of the single expo-
nential using the faster rate when a two exponential 
better described the time course. The rate of inhibition 
is clearly faster when channels are primarily closed 
(Fig. 9 D). However, using exclusively the rate obtained 
from the single-exponential fit, the relationship exhib-
its a superlinearity that does not follow immediately 
from the idea that the rate of block depends exclusively 
on Pc. For a simple two-state gating scheme where open-
ing and closing rates are at rapid equilibrium compared 
with the microscopic block rate, the observed rate 
of block might be expected to scale linearly with Pc as 
we observed that, despite identical conditions of Po, stim-
ulation, and paxilline concentrations (compare Figs. 1, 
G–H, 3 B, 4 C, and 8 A), the apparent onset of inhibi-
tion, when paxilline is washed onto a patch, appeared 
to vary substantially from patch to patch. However, with 
the realization that the paxilline-blocking equilibrium 
can be simply shifted from blocked to unblocked by 
changes in patch equilibrium conditions, we wondered 
whether consistent estimates of block onset and recov-
ery could be obtained by shifts in the equilibration con-
ditions while maintaining patches in the continuous 
presence of paxilline.
As a first step, we compared the apparent onset of 
paxilline inhibition both from direct wash-in of paxilline 
Figure 8. Kinetics of block onset is more reliably estimated by 
step changes in equilibration conditions while in the constant 
presence of paxilline rather than by wash-in of paxilline. (A) On-
set of paxilline is compared at 80 mV and 300 µM Ca2+ for two 
situations: first, simple perfusion of 100 nM paxilline over the 
cytosolic face of the face, and second, a change in equilibration 
conditions from 80 to 80 mV. Voltage protocols in each case 
are shown schematically. Available BK current was monitored by 
a 2-ms step to 160 mV applied at 0.5 Hz. Symbols over the volt-
age steps for a particular protocol correspond to the particular 
symbols showing the onset of block as a function of elapsed time, 
with single-exponential time constants as given. (B) Estimates of 
time constants from individual patches for each method of assess-
ing paxilline block are shown along with means and STD. Each 
method was evaluated with the same patches. An F-test provided 
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kc/(kc + ko). However, when the faster component of the 
inhibition onset is used for the intermediate Pc condi-
tions, the overall relationship between the fast onset of 
block and Pc is linear, with asymptote at 0, consistent 
with the idea that the initial step in block onset depends 
on Pc. One potential explanation for the two exponen-
tial components is that, at the intermediate and low Pc 
values, there are additional transitions, either from the 
gating equilibrium or the blocking mechanism, which 
contribute to the observed block onset. However, at 
present, we have no simple explanation for the basis for 
the two relaxation components at the intermediate 
Pc values. Regardless of this uncertainty, the results 
are compatible with the idea that fast components of 
inhibition vary linearly with occupancy of channels in 
closed states.
Next, we examined the concentration dependence of 
the onset of inhibition by paxilline at 80 and 100 mV 
(Fig. 9, E and F). For estimates at the highest paxilline 
concentrations, the time between test steps to monitor 
BK activation was reduced to 0.2 s (Fig. 9 F). Remark-
ably, over the range of 5 to 2,000 nM paxilline, the rate of 
block was linear, with a slope of 2.1 × 106 M1s1 (Fig. 9 G). 
Because these rates are measured under conditions in 
which the BK channels are primarily closed, this poten-
tially defines the rate of inhibition of a closed channel. 
This pseudo–first-order molecular association rate for 
paxilline interaction with a closed channel is remarkably 
similar to that of uncharged anesthetics acting upon 
nicotinic AChRs (Adams, 1976) and also the 0-voltage for-
ward rate of inhibition of quaternary ammonium blockers 
of ligand-gated channels (Neher and Steinbach, 1978; 
Lingle, 1989).
Collectively, these tests of the rate of onset of inhibi-
tion by paxilline support the idea that inhibition involves 
specific interaction with closed-channel conformations.
The paxilline unblocking rate is only mildly dependent  
on conditions that favor increased Po
The rate of unblock from paxilline may also be informa-
tive regarding the blocking mechanism. In particular, 
blocking Schemes 1 and 2 make very different predic-
tions for what might be expected during a change in 
equilibration conditions. In Scheme 1, closed channels 
stabilized by paxilline have two potential pathways for 
recovery from inhibition, one being simple unbinding 
of paxilline from the closed channel, and the other 
being unbinding after the channel has first undergone 
Figure 9. Paxilline inhibition is faster at higher closed-channel 
probabilities. (A) All traces were obtained from the same patch 
with the indicated voltage protocol while in the continuous 
presence of 100 nM paxilline and 300 µM Ca2+. Black traces cor-
respond to currents activated after a re-equilibration period at 
80 mV (with 300 µM Ca2+), whereas red traces are the final trace 
after a change to a new equilibration voltage (as indicated). 
(B) The onset of current inhibition from the examples in A is 
plotted as a function of time at the new equilibration potentials. 
Red lines are single-exponential fits to the onset of inhibition. 
(C) Onset of inhibition at intermediate Pc is better fit with two 
(blue) exponential components than one (red). (D) The rate of 
block (means, SEMs, and individual estimates) from experiments 
as in B is plotted as a function of Pc, with Pc calculated from the 
G-V curves at 300 µM Ca2+. Closed red symbols correspond to the 
faster rate resulting from the fit of either one or two exponential 
components to the onset time course in B and C. (E and F) Onset 
of inhibition at 80 mV (E) and 100 mV (F) is shown for dif-
ferent paxilline concentrations along with single-exponential fits. 
(G) Blocking rate is plotted as a function of [paxilline]. The fitted 
red line has a slope of 2.1 × 106 M1s1. Each dotted line connects 
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160 mV, which by itself produces no effect on paxilline 
recovery. The time course of recovery was essentially 
identical for either recovery procedure, i.e., a change in 
equilibration condition (black symbols in Fig. 10 A) or 
washout of paxilline (red symbols in Fig. 10 A). The 
time constant of recovery was about twofold briefer at 
80 mV compared with 0 mV. At more negative voltages 
corresponding to conditions of lower Po, the fractional 
unblock resulting from a change in equilibration condi-
tions precluded careful delineation of the recovery time 
course. However, the correspondence of the time con-
stants measured either from washout or the change 
in equilibration allowed simple washout of paxilline to 
be used to define unblock at conditions of lower Po 
(Fig. 10 B). For another patch, after the development of 
inhibition by three separate applications of 100 nM pax-
illine at 80 mV with 300 µM Ca2+, recovery from inhi-
bition was monitored at 80, 40, and 0 mV (Fig. 10 B), 
a closed to open conformational change. For Scheme 2, 
unblock can only occur from the closed state. There-
fore, Scheme 1 predicts that unblock may be favored by 
conditions that increase Po, whereas Scheme 2 predicts 
that the rates of recovery will only depend on dissocia-
tion of paxilline from closed conformations. However, 
in accordance with Scheme 1, given that paxilline has a 
strong effect on the C-O equilibrium, i.e., Ep of 0.002, 
the C to O transition for paxilline-bound channels may 
still be sufficiently small so that unblock only arises from 
paxilline unblock from closed channels.
To examine unblocking kinetics, we first allowed 
block in 100 nM paxilline to develop at 80 mV with 
300 µM Ca2+. We then examined unblock from paxil-
line either after a change to an equilibration condition 
of higher Po in the constant presence of paxilline or 
after washout of paxilline. Recovery of channels from 
paxilline inhibition was assessed by brief test steps to 
Figure 10. Recovery from paxilline inhibition is 
faster at higher Po. (A) Unblock time constant from 
washout of paxilline is comparable to unblock dur-
ing change in equilibration conditions. The panels 
are all from the same patch, with the unblocking 
time course examined at 0 (top), 40 (middle), or 
80 mV (bottom). Black symbols and fitted line corre-
spond to unblock in the constant presence of 100 nM 
paxilline after a change in equilibration condition 
from 80 mV, 300 µM Ca2+ to each of the three volt-
ages. Red symbols and fitted red lines correspond to 
washout of paxilline at the indicated voltage with 
300 µM Ca2+. BK availability was assessed with brief 
test steps to 160 mV. Po during the recovery condi-
tions was estimated from G-V curves as 0.7 (0 mV, 
top), 0.85 (40 mV, middle), and 0.9 (80 mV, 
bottom). (B) Recovery time course was compared in 
the same patch for washout of paxilline at 0 (Po of 
0.7), 40 (Po of 0.4), and 80 mV (Po of 0.1), 
all in 300 µM Ca2+. (C) Recovery time course from A 
(middle) for washout of paxilline is plotted on a 
logarithmic scale along with fits of an exponential 
of form I(t) = (1  exp(t/tau)n, for n = 1, 2, or 4. 
(D) Open circles show recovery time constants for 
patches examined as in A, with closed symbols cor-
responding to time constants measured during pax-
illine washout, and open circles corresponding to 
the constant presence of paxilline, with each point 
reflecting the mean of at least four patches. Closed 
diamonds correspond to time constants measured 
as in B. The fitted G-V curve (Vh = 34.0 mV; z = 
0.98) for currents activated in the patches in A and 
B is shown to highlight the extent of changes in 
fractional activation for the different recovery con-
ditions. Red symbols correspond to seven patches 
for which recovery was measured at 0 mV in the 
constant presence of either 100 nM paxilline (red 
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difference in paxilline concentration was associated with 
a 1.6-fold different in recovery time constant. This weak 
concentration dependence seems curious given the 
similarity of recovery from inhibition by 100 nM paxil-
line, when recovery occurs either with or without paxil-
line. We potentially attribute this difference to the idea 
that channels recovering at 0 mV from inhibition by 
20 nM paxilline begin with only slightly more blocked 
channels than unblocked channels, whereas channels 
recovering with 100 nM paxilline start primarily from 
blocked states. We noted above that the time course of 
inhibition onset at intermediate Po levels exhibits some 
complexity, perhaps reflecting the contributions of mul-
tiple transitions to the observed relaxations. We suggest 
that the same may apply when comparing unblock at 
20 nM paxilline to that at 100 nM paxilline.
Collectively, these tests show that conditions of in-
creased Po only weakly increase the rate of recovery 
from paxilline inhibition and only at the most positive 
Po’s. The absence of any obvious effect of conditions 
favoring channel opening on unblock at potentials neg-
ative to 0 mV suggests that, under such conditions, inhi-
bition by paxilline is defined solely by the rates of 
association to and dissociation from the closed chan-
nels. Excluding the possibility that paxilline binding is 
directly influenced by voltage and/or Ca2+, we favor the 
view that the weak Po dependence of unblock rate at 
positive voltages is consistent with Scheme 1; that is, 
some closed channels bound with paxilline recover by 
first opening, which then permits faster dissociation of 
revealing essentially no difference in recovery time course 
among these three conditions.
Analysis of recovery time course can also be useful 
in distinguishing among different types of inhibitory 
mechanisms. The single-exponential nature of the re-
covery time course is consistent with a single rate-limiting 
step, perhaps paxilline unbinding, underlying the recov-
ery as embodied in Scheme 1. A different category of 
model not considered in the analysis of steady-state in-
hibition would involve multiple, identically bound pax-
illine molecules, each of which must dissociate before 
unblock occurs. In such a case, the time course of recov-
ery is expected to exhibit a lag, consistent with the num-
ber of recovery steps. However, we found that the recovery 
time course, when defined by I(t) = (1  exp(t/tau))n, 
consistently yields values near 1 (Fig. 10 C), whereas 
constraining n = 2 or 4 totally fails to describe the recov-
ery time course. Thus, there is no indication of any delay 
in the onset of a single-exponential unblocking process.
Mean values from similar recovery experiments re-
vealed little obvious difference in unblocking time con-
stants from 80 to 0 mV, with only a modestly faster 
time constant at more positive voltages (Fig. 10 D). It is 
noteworthy that, after a change in the voltage to allow 
unblock to occur, the recovery time course is essentially 
identical whether paxilline remains in the solution or is 
washed out. However, in another set of seven patches, 
we explicitly measured recovery at 0 mV in the constant 
presence of paxilline, with paxilline either at 20 or 100 nM 
(red symbols in Fig. 10 D). In this case, the fivefold 
Figure 11. Manipulation of BK Po by MTS modifica-
tion of S6 residues also modulates paxilline sensitiv-
ity. (A) Traces on the top show that 100 nM paxilline 
readily blocks Slo1-A313C currents, but after modi-
fication of A313C with MTSET, paxilline produces 
hardly any block of the residual current. (B) The 
normalized conductances from the experiment 
shown in A are plotted for A313C in the absence 
and presence of paxilline, and then after modifica-
tion by MTSET. Slo1-A313C-MTSET is constitutively 
active over the potentials examined. (C) Results are 
shown for Slo1-A313C before and after modification 
by MTSEA. Modification by MTSEA produces less 
G-V shift than for modification by MTSET, whereas 
block by paxilline is also intermediate. (D) Similar 
results are shown for Slo1-A313C before and after 
modification by MTSES. MTSES produces only mod-
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modification, the BK fractional Po at 0 mV and 10 µM 
Ca2+ was 0.48, whereas 100 nM paxilline produced a 
fractional block of 0.5. Modification of Slo1-A313C by 
the negatively charged MTSES resulted in a modest left-
ward gating shift, and inhibition by 100 nM paxilline of 
the modified channels (Po at equilibration conditions 
was 0.12) was only slightly weaker than that for inhibi-
tion of the unmodified Slo1-A313C channels.
Although the three MTS reagents differ in net charge 
conferred on the modified Cys residue, they are of 
generally similar size. Give that paxilline is neutral at 
physiological pH, it seems highly unlikely that the dif-
ferences among MTS moieties on the extent of paxil-
line inhibition reflect either electrostatic or steric 
hindrance of paxilline binding. On the other hand, 
the reduction in paxilline sensitivity of MTS-modified 
A313C channels provides further support for the view 
that inhibition by paxilline is inversely correlated with 
increases in channel Po.
Access of paxilline to its blocking position is hindered  
by compounds thought to occupy the inner pore
The ability of the G311S mutation to disrupt paxilline 
blockade and the key role of Slo1 S6 in inhibition by 
paxilline suggest that the BK channel central cavity may 
play a role in paxilline blockade (Zhou et al., 2010). 
Furthermore, the results showing that binding of a sin-
gle paxilline molecule produces inhibition also suggest 
an action of paxilline on the axis of the permeation path-
way. To further address this issue, we have asked whether 
compounds known to occupy the BK inner pore may 
hinder paxilline inhibition. We used two different tests: 
first, examination of the onset of paxilline inhibition in 
the presence of a bulky pore blocker; and second, ex-
amination of the ability of sucrose, an impermeant sol-
ute known to occupy the BK inner cavity (Brelidze and 
Magleby, 2005), to impede paxilline inhibition.
As a BK channel pore blocker, we used the bulky mol-
ecule N-(4-[benzoyl]benzyl)-N,N,N-tributylammonium 
(bbTBA), which has been shown previously to block 
both open and closed BK channels (Wilkens and Aldrich, 
2006; Tang et al., 2009). For any pair of pore blockers, 
if one determines the steady-state block produced by 
each agent producing near half-maximal block, exami-
nation of the blocking effects of both applied together 
potentially allows discrimination between competitive 
and noncompetitive mechanisms. In fact, this was used 
to show that inhibition of BK channels by TBA and 
bbTBA occurs in a competitive fashion (Wilkens and 
Aldrich, 2006). However, this approach works best for 
rapid blockers, where onset and recovery from block al-
lows ready determination of the fractional block under 
any condition. In the present case, we are coupling a 
faster blocker, bbTBA, with a slower blocker, paxilline. 
As a consequence, we chose a different strategy that 
takes advantage of the fact that the washout of bbTBA 
paxilline, reflecting the very weak affinity of paxilline to 
the open channel. That unblocking rates are not more 
strongly Po dependent suggests that paxilline unbind-
ing from closed states is still relatively rapid compared 
with opening of the paxilline-closed state, even at posi-
tive voltages and high Ca2+.
The above interpretation suggests that the time con-
stants of recovery measured at negative voltages reflect 
the dissociation rate of paxilline from closed channels. 
The mean time constant at 80 mV of 37.0 s corre-
sponds to a rate of 0.027/s. From the forward rate of 
paxilline block to closed channels of 2.1 × 106 M1s1 
(Fig. 9 F), the affinity of paxilline to the closed BK chan-
nel calculated from the kinetic estimates is 12.9 nM, in 
quite satisfactory agreement with the estimates of paxil-
line affinity for the closed channel based on inhibition 
of steady-state currents (Fig. 6 E).
Pore modification with MTS reagents alters paxilline 
inhibition in a fashion consistent with the inverse 
dependence of inhibition on Po
MTS modification of a cysteine introduced at A313 in 
the BK S6 helix shifts BK G-V curves to more negative 
potentials (Zhou et al., 2011). The extent of the gating 
shift depends on the MTS reagent, with MTSET result-
ing in the largest shifts. We therefore wondered whether 
gating shifts produced by the MTS reagents might alter 
paxilline sensitivity in a fashion consistent with the Po 
dependence of paxilline block. We first defined the 
paxilline sensitivity of the unmodified A313C construct 
(Fig. 11, A and B). 100 nM paxilline resulted in strong 
block of the Slo1-A313C current. The application of 
100 µM MTSET resulted in an irreversible modification 
of the Slo1-A313C current with strong current rectifica-
tion at positive potentials, reflecting a voltage-dependent 
reduction of single-channel conductance by the MTSET 
attached to A313C (Zhou et al., 2011). Furthermore, 
modification by MTSET produces an essentially constitu-
tive activation of current at negative potentials (Fig. 11 A), 
as indicated by G-V curves generated from the Slo1-
A313C-MTSET tail currents (Fig. 11 B). The application 
of 100 nM paxilline to the MTSET-modified channel 
produced only a small reduction in current (Fig. 11 A). 
The Po of the MTSET-modified Slo1-A313C channels 
was 0.9 at 0 mV with 10 µM Ca2+, whereas the frac-
tional block by paxilline was <0.1.
The disruption of paxilline inhibition of the MTSET-
modified channel might arise either from the inability 
of paxilline to inhibit open BK channels as developed 
above or from inhibition by MTSET of access of paxil-
line to its blocking site. To further address this issue, we 
examined the consequences of modification of A313C 
by either MTSEA (Fig. 11 C) or MTSES (Fig. 11 D). 
Modification of A313C by the neutral MTSEA resulted 
in a substantive leftward shift in BK gating, but not 
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number of channels blocked by paxilline was reduced 
50%. The fractional reduction of block is about that 
expected for a competitive model for each compound 
being applied at 10-fold their estimated dissociation 
constants.
One simple interpretation of this result would be that 
the presence of bbTBA in the BK central cavity prevents 
or slows access of paxilline to its blocking position. How-
ever, it might also be considered that perhaps bbTBA 
reduces paxilline inhibition because the presence of 
bbTBA in the inner cavity mimics a BK channel open 
conformation, which we have shown above has reduced 
affinity for paxilline. We consider the latter possibility 
unlikely because of three factors: first, under the equili-
bration conditions of this experiment (0 mV, 10 µM 
Ca2+), the BK Po is low (0.05), such that channels are 
predominantly in closed states; second, under these con-
ditions, bbTBA will occupy both open and closed chan-
nels with about equal affinity (Wilkens and Aldrich, 
2006; Tang et al., 2009); and third, bbTBA has minimal 
ability to hinder the BK channel open-to-closed transi-
tion, so it is unlikely that it stabilizes the open confor-
mation (Wilkens and Aldrich, 2006; Tang et al., 2009).
In our second test, we used 2 M sucrose, which has 
been shown to produce a marked reduction of outward 
potassium flux through BK channels, largely from bulk 
occupancy of the BK channel central cavity (Brelidze 
and Magleby, 2005). We first confirmed this effect of 
2 M on macroscopic BK currents (Fig. 12 B), which 
will be essentially complete before any channels blocked 
by paxilline will have unblocked. Reasoning that channels, 
once blocked by paxilline, will recover from paxilline 
inhibition slowly, we examined whether the presence of 
bbTBA might reduce the fraction of channels blocked 
by paxilline.
We used 100 µM bbTBA, a concentration that ex-
ceeds the channel blocking affinity by 10-fold (Wilkens 
and Aldrich, 2006; Tang et al., 2009). An advantage of 
the use of bbTBA is that it has been shown to occupy 
both closed and open BK channels. We then examined 
block by 100 nM paxilline, which is also near 10-fold the 
estimated affinity of block for the closed BK channel. 
An example of such an experiment is shown in Fig. 12. 
Currents were activated by voltage steps to 160 mV 
under equilibration conditions of 0 mV and 10 µM Ca2+. 
100 µM bbTBA was first applied to the patch to establish 
the time course of bbTBA block and unblock. 100 nM 
paxilline was then applied to the patch for 40 s and 
then washed out. Block was incomplete but current was 
reduced 80% before washout. Subsequently, 100 µM 
bbTBA was applied simultaneously with 100 nM paxil-
line for the same duration of application as with 100 nM 
paxilline alone. With both agents together, currents are 
completely blocked. However, upon washout, currents 
return to a level 50% of the blocked level observed 
with paxilline alone, and then slowly recover with a time 
course characteristic of unblock from paxilline. This 
indicates that, in the presence of 100 µM bbTBA, the 
Figure 12. bbTBA and sucrose each slow paxilline 
inhibition. (A) Blockade of Slo1 current by 100 nM 
paxilline is displayed with and without simultane-
ous application of 100 µM bbTBA. The equilibra-
tion conditions were 0 mV with 10 µM Ca2+, and BK 
current availability was monitored by voltage steps 
to 160 mV applied at 1 Hz. Blocker applications are 
shown with horizontal bars, with all measurements 
from the same patch. Block and unblock with 100 µM 
bbTBA alone (black) is rapid, whereas block by 
100 nM paxilline (red) alone exhibits slow onset 
and recovery. After simultaneous application of pax-
illine with 100 µM bbTBA, the amount of paxilline 
inhibition is reduced about half. (B) BK currents 
were activated with 300 µM Ca2+ with the indicated 
voltage protocol without and with the addition of 
2 M sucrose to the cytosolic solution. Insets show 
currents with a red trace at 20 mV. Sucrose mark-
edly reduces outward current, whereas tail currents 
at 120 mV are reduced a little more than half. For 
control solutions, Vh = 16.3 ± 7.2 mV, whereas with 
2 M sucrose, Vh = 12.8 ± 3.3 mV. (C) 100 nM pax-
illine strongly inhibits BK current, whereas in 2 M 
sucrose, both outward and inward currents are only 
slightly affected by paxilline. Top traces are single 
sweeps. Bottom traces correspond to an average 
of 15 sweeps before, during, and after washout of 
100 nM paxilline. (D) Plot of time course of paxil-
line inhibition without and with 2 M sucrose suggests 
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or inner cavity occupancy by sucrose. To address whether 
paxilline may hinder access of small molecules to the 
central cavity, we again took advantage of the ability of 
MTSET to modify pore residue A313C, both in open and 
closed states (Zhou et al., 2011). Modification of A313C 
by 1 mM MTSET of closed BK channels occurs with a 
time constant of 23 s and is associated with a >50% re-
duction in maximal conductance, as a result of effects on 
single-channel conductance (Zhou et al., 2011). Modifi-
cation of A313C in open states is 200-fold more rapid. 
Here, because our results suggest that paxilline may only 
act on closed BK channels, we specifically asked whether 
the presence of paxilline would hinder the ability of resi-
due A313C to be modified by MTSET when channels 
are closed. First, we confirmed the extent of modification 
of closed (80 mV, 0 Ca2+) A313C channels by a 120-s 
application of 1 mM MTSET in the absence of paxil-
line (Fig. 13 A). For a time constant of 23 s, modification 
should be >99% complete at 120 s. The G-V curve after 
MTSET modification (Fig. 13 C) exhibits a substantial 
shift as observed previously, although less shifted than 
reported previously for open-state modification of A313C 
(Zhou et al., 2011). In separate patches, we then exam-
ined whether 500 nM paxilline hindered modification 
by a similar application of MTSET (Fig. 13, B and C). 
We found no difference in modification with or 
showed that sucrose markedly suppressed outward cur-
rents, with a weaker effect on inward K+ current. Analy-
sis of the tail currents monitored at 120 mV revealed 
little shift in the Vh of activation (Fig. 12 B). The appli-
cation of 100 nM paxilline before the addition of su-
crose to the cytosolic solution produced the expected 
robust inhibition of current, whereas with 2 M sucrose 
added to the cytosolic solution, only a weak inhibition 
of BK current was observed with paxilline (Fig. 12 C). 
The time course of onset of paxilline inhibition with 2 M 
sucrose suggests that inhibition develops more slowly in 
paxilline (Fig. 12 D), also consistent with the idea that 
the presence of sucrose in the central cavity may impede 
access of paxilline to its final binding position.
With the assumption that bbTBA and sucrose do not 
exert any effects independent of the central cavity, col-
lectively, the bbTBA and sucrose experiments support 
the idea that paxilline is hindered from reaching its in-
hibitory position, when the central cavity is occupied by 
other bulky molecules.
Paxilline does not alter the ability of MTSET  
to modify A313C
Although the above experiments show that paxilline in-
hibition is hindered by bbTBA and sucrose, they do not 
address whether paxilline hinders inhibition by bbTBA 
Figure 13. Paxilline does not 
hinder MTSET modification of 
A313C. (A; top) The traces show 
currents activated with 300 µM 
Ca2+ at voltage steps up to 200 mV 
for channels arising from Slo1-
C430S-A313C. (Bottom) Cur-
rents were similarly elicited, but 
after 120 s of application of 1 mM 
MTSET while holding the patch 
at 80 mV with 0 Ca2+. (B; top) 
The traces show current for Slo1-
C405A-A313C activated with 
300 µM Ca2+. The patch was then 
first perfused with 500 nM pax-
illine for 100 s while holding at 
80 mV with 0 Ca2+, and then 
exposed to 1 mM MTSET with 
500 nM paxilline for 120 s while 
still at 80 mV with 0 Ca2+. (C) G-V 
curves summarize results from 
patches examined for condi-
tions shown in A and B. Because 
MTSET modification was tested 
both without and with paxilline, 
two separate sets of control G-V 
curves at 300 µM Ca2+ are shown. 
(D) BK currents were recorded 
in 300 µM Ca2+ before (left) and 
after (top right) modification by 
1 mM MTSET, applied for 120 s in 0 Ca2+ at 80 mV. Modification is similar to that in A. The patch was then held at 0 mV, 0 Ca2+, and 
then channels were opened by 20 100-msec steps to 160 mV, after which the traces on the bottom right were obtained in 300 µM Ca2+. 
(E) G-V curves correspond to conditions as in D for control, after closed-state modification by 1 mM MTSET, and then after subsequent 
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the results suggest that the binding of small molecules 
to an ion channel can produce channel inhibition by 
stabilization of the closed-channel conformation, with-
out any occlusion of the open-channel ion permeation 
pathway or effects on voltage sensors. An implication of 
the strong closed-state dependence of the inhibition is 
that the ability of paxilline to inhibit BK current among 
different cells will vary depending on the resting Po in a 
given cell. Thus, some caution may be required in the 
application of paxilline as a diagnostic tool for the pres-
ence of BK channels, if BK subunit composition and 
resting Ca2+ is such that the resting Po is high. Below, we 
consider the paxilline inhibitory mechanism within the 
context of other channel inhibitory mechanisms and 
discuss our results in terms of potential structural bases 
of the paxilline effects.
Categories of closed-channel block
In “open-channel block,” upon channel opening, a 
blocking molecule simply moves from bulk solution 
into a position within the central axis of an ion perme-
ation pathway that physically occludes ion permeation. 
In contrast, “closed-channel block” may include any of 
a variety of allosteric effects, often occurring in associa-
tion with direct blocking effects. For many blockers for 
which a closed-channel block effect has been described, 
the underlying mechanisms remain largely unknown 
and, in most cases, a compound will produce both open- 
and closed-channel block effects.
The simplest category of closed-channel blocker is 
one in which the blocker is able to access a position in 
the closed channel that, once the channel opens, will 
occlude ion permeation. This might occur in either of 
two ways: first, lipophilic molecules may pass through 
hydrophobic pathways to reach a position suitable for 
pore occlusion, as originally proposed for uncharged 
local anesthetics acting on Na+ channels (Hille, 1977); 
and second, some channels may have a relatively acces-
sible inner cavity allowing access of charged blocking 
molecules both in closed and open states, as proposed 
for blockade of BK channels by bulky quaternary block-
ers (Wilkens and Aldrich, 2006; Tang et al., 2009).
The idea that lipophilic blocking agents might access 
blocking sites within closed ion channels was probably 
first considered in classical studies of local anesthetic 
block of Na+ channels in the node of Ranvier (Hille, 
1977). This work suggested that both charged and un-
charged anesthetics reached a similar blocking position 
within the channel but reached the blocking site by dis-
tinct pathways: charged species required the opening of 
a cytosolic gate to reach a blocking position, whereas 
uncharged species are able to reach the same blocking 
position via a hydrophobic region of the protein. This 
idea that both categories of compounds reach similar 
positions within the Na+ channel aqueous cavity has 
recently been supported in modeling work (Bruhova 
without paxilline, although BK current was completely 
inhibited by paxilline during the application of 
MTSET. At 500 nM paxilline and a paxilline-binding 
constant of 10 nM, channels will be occupied by paxil-
line 98% of the time. If MTSET can only modify BK 
channels during that 2% of the time that paxilline is 
not present, based on the previously defined rate of 
MTSET modification of closed channels, essentially no 
modification by MTSET should be observed. This re-
sult therefore clearly shows that paxilline does not hin-
der MTSET modification of position A313C in closed 
BK channels.
Given that the partial G-V shift observed for MTSET 
modification of closed channels differs from the essen-
tially constitutive activation of BK channels modified 
by MTSET while in open states (Zhou et al., 2011), we 
wondered whether the partial modification might sim-
ply reflect loss of reactive MTSET during the 120 s of 
MTSET application. To address this issue, a set of 
patches was first modified by MTSET while channels 
were held in closed states by bathing the patch in 0 Ca2+ 
at 80 mV (Fig. 13 D). Subsequently, the same MTSET 
solution was then applied while channels were held in 
high Po conditions. This was accomplished by changing 
the holding condition to 0 mV at 0 Ca2+ but applying 
20 voltage steps to 160 mV, each of 100-ms duration. In 
this case, additional modification by MTSET readily oc-
curred resulting in channels that are essentially consti-
tutively open over a wide range of voltages, similar to 
the earlier observations (Zhou et al., 2011). This indi-
cates that channels modified by MTSET while in closed 
states have different gating properties than those modi-
fied in open states. Using single-channel recordings, 
our previous work showed that two distinct step changes 
in single-channel current can be observed during modi-
fication of A313C by MTSET (Zhou et al., 2011), pre-
sumably corresponding to the sequential modification 
of at least two distinct A313C cysteines. We therefore 
propose that in the closed BK channel, the dimensions 
of the inner cavity are such that modification by only a 
single MTSET can be accommodated. In contrast, in 
the open channel, the volume allows modification at two 
A313C positions. The differences in the gating shifts 
after closed- and open-state modification reflect the ef-
fects of modification at either a single subunit or a pair 
of subunits. Regardless of this nuance of MTSET modi-
fication at position A313C, the important point is that 
wherever the position of paxilline inhibition, it does 
not hinder the ability of MTSET to modify at least one 
A313C residue.
D I S C U S S I ON
These results describe a mechanism of inhibition of BK 
channels that, to our knowledge, is unique not only for 
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particular, might have evolved to exploit other ways of 
stabilizing channels in closed states.
Considerations regarding the physical basis  
of paxilline inhibition
The paxilline inhibition of BK channels appears to ex-
hibit features unique among previously reported closed-
channel blocking effects on K+ channels. First, the 
closed-channel block effects occur in the almost com-
plete absence of open-channel block. Second, the paxil-
line inhibitory effect can be described by allosteric 
regulation of the central C-O equilibrium. Do the pres-
ent results allow for any inferences regarding the physi-
cal basis for such effects? In the absence of structural 
information, definitive answers regarding the paxilline 
site of action are not possible. However, here we consider 
two topics: first, the route of paxilline access to its inhi-
bitory positions; and second, the number of paxilline-
binding sites on a channel.
For a lipophilic molecule like paxilline (logP = 3.62), 
it is natural to wonder whether paxilline reaches its po-
sition of inhibition from the paxilline reservoir in the 
membrane. Several results are pertinent to this topic. 
The ability of both the bulky pore blocker, bbTBA, and 
high concentrations of the impermeant solute, sucrose, 
to impede paxilline inhibition would seem to argue 
against the possibility that paxilline reaches its site of 
inhibition via the bulk lipid membrane. Neither bbTBA 
nor sucrose would be expected to impede the partition-
ing of paxilline into lipid or movement from lipid into 
channel protein. We consider it less likely that inter-
ference of bbTBA and sucrose of paxilline inhibition 
would arise, because of some steric effect of pore occu-
pancy preventing lateral diffusion of paxilline through 
the protein into an inhibitory position.
Our measurement of the paxilline concentration 
dependence of inhibition of closed channels may also 
provide insight into the source of paxilline-mediating 
inhibition. We measured a forward rate of inhibition 
that was linear up through 2 µM paxilline with a slope 
of 2 × 106 M1s1. This is very similar to rates of open-
channel block of several other ion channels, both for 
uncharged anesthetics (Adams, 1976) and for charged 
anesthetics at 0 mV (Neher and Steinbach, 1978; Lingle, 
1989). For bbTBA block of BK channels, at 100 mV the 
forward rate of block is 1.2 × 108 M1s1 (Wilkens and 
Aldrich, 2006). Assuming a z of 0.148 e assigned to the 
forward rate, this reflects a 0-voltage forward rate of 
6.7 × 107 M1s1. This is faster than what we observe for 
paxilline inhibition in closed states, but experiments 
examining state-dependent modification of cysteines 
introduced into BK S6 reveal a more than two orders of 
magnitude difference for MTS modification rates of 
residues in open versus closed channels (Zhou et al., 
2011). The linearity of the rate as a function of paxilline 
concentration suggests that, even when channels are 
et al., 2008). More recently, it has become clear that 
local anesthetics may exert two types of effects on Na+ 
channels: one involving allosteric effects on voltage sen-
sors, and a second corresponding to more traditional 
pore occupancy and occlusion (Hanck et al., 2009; 
Muroi and Chanda, 2009).
For closed-channel inhibition of BK channels, bbTBA 
and other quaternary blockers appear to gain access to 
the central cavity of the pore in both open- and closed-
channel conformations (Wilkens and Aldrich, 2006; 
Tang et al., 2009), with little difference in apparent af-
finities of interaction for open and closed channels. 
The idea that the BK central cavity is accessible in closed 
states has also been supported by work showing that cys-
teine residues introduced in the BK S6 at positions that 
would be expected to be inaccessible in closed Kv chan-
nels can be readily modified by charged MTS reagents, 
even in closed states in BK channels, albeit at rates 
slower than the modification of open channels (Zhou 
et al., 2011). The closed-channel inhibition of BK chan-
nels by bbTBA, like that of local anesthetics on Na+ chan-
nels, represents essentially a simple pore occupancy 
model, with little difference in block between closed 
and open states.
For the two types of two cases of closed-channel block 
just described, both open- and closed-channel block 
contribute to the overall channel inhibitory effect. How-
ever, an interesting case of closed-channel block that 
deviates from this generality is that of tetracaine inhibi-
tion of CNG channels (Fodor et al., 1997a,b) for which 
the affinity of tetracaine for closed channels is 1,000-
fold stronger than for affinity to open channels. CNG 
channels share with BK channels the ability for mole-
cules to enter the inner cavity in both open and closed 
states, allowing modification of pore-lining–introduced 
cysteines (Flynn and Zagotta, 2003). For inhibition by 
tetracaine, inhibition has been suggested to arise from a 
snug fit within the CNG inner cavity, but the conforma-
tional changes within the inner cavity favor binding to 
the closed state, but not to the open (Fodor et al., 1997a). 
Intriguingly, mutation of E363G, a residue presumably 
on the extracellular end of the CNG selectivity filter, 
abolishes the state dependence of tetracaine inhibition 
(Fodor et al., 1997a), supporting the idea that closed-
state inhibition by tetracaine involves a snug positioning 
of tetracaine in the vicinity of the selectivity filter.
In contrast to the pore occupancy models or occlu-
sion by toxins on the extracellular face of channels, 
closed-channel block by voltage-sensor toxins, such as 
hanatoxin (Lee et al., 2003), represents the perhaps 
clearest example of a compound acting at positions that 
are not in the axis of the ion permeation pathway, such 
that the inhibition of channel activation clearly must be 
allosteric. Given the allosteric nature of ion channel 
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of recovery from inhibition, as each of the up to four 
paxilline molecules must unbind before unblock oc-
curs. This is not observed.
If the binding of a single paxilline molecule does pro-
duce BK channel inhibition, this is most consistent with 
a binding site that is located along the axis of the per-
meation pathway. In the present case, this possibility is 
given some support by both the bbTBA and sucrose re-
sults. A caution to this idea is the possibility that the 
hydrophobic bbTBA and the bulk effects of the high 
solution concentration with sucrose might conceivably 
hinder the action of a compound at other positions un-
related to their pore occupancy. However, at present, 
there is no precedent for such alternative effects, so the 
idea that bbTBA, sucrose, and paxilline interact within 
or in close juxtaposition to the pore would seem the 
most likely situation.
However, the one result that raises some question in 
regards to the idea of paxilline inhibition involving a 
single site along the axis of the permeation pathway is 
the failure of paxilline to prevent MTSET modification 
of position A313C in closed conformations. This result 
clearly argues against one simple view of paxilline ac-
tion, namely that paxilline acts to occlude the entrance 
to the inner cavity, but only in the closed states (Fig. 14 A). 
We think it unlikely that this result can be explained by 
the possibility that both paxilline and MTSET might si-
multaneously occupy positions in the inner cavity. Over-
all, is there a way to reconcile the ability of bbTBA and 
sucrose to hinder paxilline inhibition with the lack of 
effect of paxilline on MTSET modification? We see no 
obvious simple explanation for this set of results based 
on our current understanding, but point to two possi-
bilities. First, for BK, essentially nothing is known about 
the positioning of S6 helices as they traverse from the 
membrane-associated pore-gate domain to link with the 
appended cytosolic ligand–sensing domain. Do the cy-
tosolic ends of the inner helices define a tightly packed 
funnel through which any permeant ion or blocker 
must pass to reach the central cavity, or is there some 
splayed arrangement of the cytosolic ends of the helices 
that may allow passage of solutes both down and be-
tween the helices to reach the central axis of the perme-
ation pathway? In the latter case, even if a compound 
were to occupy a position within the tetrad of inner he-
lices, thereby stabilizing a closed conformation, per-
haps pathways for compounds to reach the inner cavity 
might still exist (Fig. 14 B). Assuming strict homology of 
the pore-gate domain of the Slo1 family of channels to 
Kv channels, this possibility would seem unlikely. How-
ever, many examples now exist of ways that the BK S6 
helix and inner cavity differ from that of Kv channels. 
For example, residues that are likely to be pore facing 
in BK differ from those in Shaker (Chen and Aldrich, 
2011; Zhou et al., 2011; Chen et al., 2014). Similarly, the 
pattern of modifiability of BK S6 residues differs from 
largely closed, a single step, perhaps diffusionally con-
trolled encounter appears to define the block kinetics. 
That this rate is comparable to what is observed for 
open-channel blockers suggests that it reflects block oc-
curring from the aqueous milieu. However, does the 
linearity and magnitude of the blocking rate fully ex-
clude the possibility of inhibition occurring from lipid? 
Linearity in the rate implies that, over this concentration 
range, inhibition arises from the binding of paxilline 
directly to the inhibitory position, whatever the source 
of paxilline may be. However, for paxilline reaching an 
inhibitory position from bulk lipid, deviation from lin-
earity would probably be expected, if the pathway to the 
paxilline inhibitory position involved transient occu-
pancy of hydrophobic pockets along the route to the 
binding site. Although our results do not require a par-
ticular explanation, we prefer the view that the effects 
of bbTBA, sucrose, and linearity in inhibition are most 
readily explained by paxilline inhibition occurring from 
the aqueous milieu.
We now address the question of the number of high 
affinity, closed-state paxilline-binding sites per BK chan-
nel. The concentration dependence of paxilline inhi-
bition based on a specific allosteric model of channel 
inhibition (Scheme 1) suggests that inhibition arises 
from the binding of a single paxilline molecule to 
closed channels with an affinity of 10 nM. This con-
clusion rests largely on the shape of the concentration–
response curves at the highest Po values and highest 
paxilline concentrations. Schemes with multiple, identi-
cal paxilline-binding sites predict weaker inhibition at 
higher paxilline than we observed (Fig. 7). Based on 
the particular technical challenges in defining frac-
tional inhibition at high Po and paxilline, the measures 
of paxilline inhibition are more likely to be underesti-
mates than overestimates. This provides some additional 
confidence that the single-site model is most likely. How-
ever, one caution regarding the single-site mechanism is 
the possibility that, at the highest paxilline concentra-
tions, an additional, independent paxilline inhibitory 
effect might occur. If that were the case, this would pre-
vent any assertions regarding the number of identical, 
high affinity paxilline sites based on the Po dependence 
of paxilline concentration dependence.
An additional consideration relevant to this point is 
that, if paxilline were accessing its binding sites by com-
ing in laterally through the protein, we would expect 
that up to four paxilline molecules would be able to oc-
cupy such positions simultaneously. Yet, as noted, the 
concentration dependence of paxilline action is best 
explained by the action of a single paxilline molecule. If 
four paxilline molecules could bind to the channel, 
with one being sufficient for a full inhibitory effect, this 
would also be consistent with the observed steady-state 
results. However, for recovery from inhibition, unbind-
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position that does not hinder MTSET access to the inner 
cavity. If paxilline occupied a position near the entrance 
to the inner cavity, bbTBA, which is perhaps large 
enough to fully occupy the inner cavity, may hinder 
paxilline movement to its blocking position. Why the 
smaller sucrose might also reduce paxilline inhibition is 
less readily explained, except perhaps by the idea that 
sucrose at 2 mM may simply displace a sufficient volume 
to reduce the effective paxilline concentration near the 
mouth of the channel.
The uncertainties associated with reconciliation of 
the bbTBA and sucrose results and absence of effect of 
paxilline on MTSET modification of closed states leaves 
open the question of whether paxilline does act along 
the axis of the permeation pathway. Given that paxilline 
can still produce inhibition in channels with MTSES-
modified A313C makes it unlikely that paxilline inter-
acts somewhere deep in the inner cavity. The failure of 
paxilline to hinder MTSET modification of closed states 
seems to argue against occlusion of the closed channels, 
except perhaps as modeled in Fig. 14 B, for which there 
is no precedent. If inhibition occurs at a position that is 
not on the axis of the permeation pathway, one has to 
consider that there may be four distinct paxilline-bind-
ing sites per channel. Yet, our analysis of the concen-
tration dependence of paxilline inhibition supported 
a single-site model (Fig. 7 A). At present, our results do 
not allow a clear-cut answer on this point, and future 
functional or structural work that identifies residues 
likely to interact with paxilline will be required.
The role of G311 in inhibition by paxilline
The effect of mutation of G311 on paxilline sensitivity 
(Zhou et al., 2010) is unusual among all manipulations 
of BK channels we have examined. Namely, mutation of 
G311 is the only manipulation causing a rightward shift 
in BK activation at a given Ca2+ that is also associated 
with a decrease in paxilline effectiveness. This indicates 
that the effect of G311 mutation is not the result of state 
dependence, but the result of some specific change 
altering paxilline binding or effect. Interestingly, the 
pH-regulated Slo3 K+ channel is resistant to paxilline 
inhibition and also lacks the corresponding hinge gly-
cine, whereas the S300G mutation in Slo3, the hinge 
position, restores some paxilline sensitivity.
Is there a relationship between the ability of mutation 
of G311 to abolish paxilline block and the lack of block 
of open BK channels? G311 corresponds to a conserved 
glycine found in a large number of both eukaryotic and 
prokaryotic voltage-gated K+ channels (Magidovich and 
Yifrach, 2004). Because mutations at this position alter 
the C-O gating equilibrium of channels where it has 
been studied, this glycine has been termed a “gating 
hinge” (Yifrach and MacKinnon, 2002; Magidovich and 
Yifrach, 2004), and a bend in the S6 helix has been ob-
served at this position in K+ channel structures (Jiang 
that in Shaker (Zhou et al., 2011). As such, perhaps the 
difficulty in reconciling the bbTBA/sucrose results with 
the inability of paxilline to protect against MTSET mod-
ification arises from some other unusual aspect of the 
BK S6 and pore-gate domain that differs from the now 
classic Kv pore-gate domain motif. A second potential 
explanation is that perhaps paxilline does bind near the 
entrance to the closed-channel inner cavity, but in a 
Figure 14. Cartoons describing possible views of inhibition of 
closed BK channels by paxilline. (A) Schematic BK channels are 
either closed (left pair) or open (right pair). The channels are 
diagrammed with an opening at the cytosolic end of the chan-
nel, which allows small molecules in and out of the inner cavity. 
Paxilline occludes the aperture to the inner cavity in the closed 
BK channel. Binding of paxilline to the closed channel (bottom 
left) occludes the aperture to the inner cavity. The open confor-
mation either is unable to bind paxilline or does so with low af-
finity, without any occlusion of ion permeation. Dotted arrows 
indicate transitions that are either very low probability or do not 
occur. (B) Overall scheme is the same as in A, except for positions 
of inner-pore helices along alternative aqueous pathways for ac-
cess of small molecules to the inner cavity. Thus, occlusion of the 
closed-channel aperture by paxilline may not impede access of 
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must be clearly defined and maintained during steps 
that evaluate the extent of paxilline inhibition.
The state dependence of paxilline inhibition may also 
require caution in the use of paxilline as a tool for iden-
tification of the contributions of BK current in various 
cell types. An implication of the present results is that 
gating shifts produced by either  or 1 subunits may 
reduce the effectiveness of paxilline, because of the un-
usual state dependence of paxilline inhibition and not 
because of a subunit-specific effect. Work in progress 
supports this idea (unpublished data). In most cases, 
this will probably not be a problem, as normal cell- 
resting potentials and normal intracellular Ca2+ con-
centrations will usually ensure that paxilline inhibition 
will be effective. However, if a particular stimulus para-
digm results in robust cellular depolarization and Ca2+ 
elevation over tens of seconds, this may be sufficient to 
reverse inhibition by paxilline such that the role of BK 
channels may be partially obscured with particular sub-
unit combinations.
Summary
Inhibition of BK channels by paxilline involves strong 
stabilization of closed conformations, with paxilline af-
finity for closed channels being 1,000-fold stronger 
than for open channels. Various criteria suggest that 
paxilline reaches its blocking position from the cyto-
solic aqueous milieu, perhaps involving an interaction 
near the entrance to the inner cavity. The unusual state 
dependence of paxilline inhibition requires caution in 
the use of paxilline in cellular systems, where condi-
tions of Po of the BK channels may not be well known.
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